Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Select Pharmaceuticals Portfolio

+ Add to Watchlist

FPHAX:US

23.76 USD 0.05 0.21%

As of 09:29:30 ET on 04/24/2015.

Snapshot for Fidelity Select Pharmaceuticals Portfolio (FPHAX)

Year To Date: +15.72% 3-Month: +11.60% 3-Year: +29.62% 52-Week Range: 18.00 - 23.81
1-Month: +2.58% 1-Year: +32.23% 5-Year: +23.81% Beta vs MXWO: 0.95

Mutual Fund Chart for FPHAX

No chart data available.
  • FPHAX:US 23.76
  • 1M
  • 1Y
Interactive FPHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FPHAX

Fidelity Select Pharmaceuticals Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types.

Inception Date: 06-18-2001 Telephone: 1-800-544-6666
Managers: ASHER ANOLIC
Web Site: www.fidelity.com

Fundamentals for FPHAX

NAV (on 2015-04-24) 23.76
Assets (M) (on 2015-03-31) 1,997.30
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FPHAX

Dividend Type Income
Dividend Frequency Semi-Anl
Last Dividend Net (on 2015-04-10) 0.04
Dividend Yield (ttm) 8.90

Fees & Expenses for FPHAX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.00
Expense Ratio 0.81

Top Fund Holdings for FPHAX

Filing Date: 02/28/2015
Name Position Value % of Total
Actavis plc 568,907 165,756,744 8.744%
Sanofi 2,984,222 145,809,087 7.692%
Johnson & Johnson 1,338,600 137,219,886 7.239%
Bristol-Myers Squibb Co 1,731,910 105,507,957 5.566%
AbbVie Inc 1,679,590 101,615,195 5.361%
Novartis AG 900,298 92,190,515 4.863%
Novo Nordisk A/S 1,635,400 78,090,350 4.120%
Teva Pharmaceutical Industries 1,306,989 74,524,513 3.931%
Allergan Inc/United States 268,900 62,583,786 3.302%
Mallinckrodt PLC 532,600 62,165,072 3.279%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil